We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

600392:SSEShenghe Resources Holding Co., Ltd. Class A Analysis

Data as of 2026-03-17 - not real-time

CN¥23.95

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Shenghe Resources is riding a strong revenue surge of 52.6% YoY while its price trades just above a key technical support of 23.93 CNY, barely above the 20‑day SMA and well below the 200‑day SMA, indicating a bullish long‑term trend but a short‑term pull‑back. The stock’s valuation appears stretched with a trailing P/E of 47.9 and a price‑to‑book of 3.16, yet margins are thin (gross ~9.5%, net ~6.6%) and cash generation is negative, raising concerns about sustainability. Technical signals are mixed: RSI at 37 suggests modest oversold pressure, but a bearish MACD histogram and decreasing volume point to weakening momentum. Volatility is extreme at 89% over the past 30 days, though beta is low (~0.33), implying price swings are driven more by company‑specific factors than market moves.
Given the high valuation, cash‑flow deficits, and elevated volatility, the near‑term outlook is cautious, while the secular growth of rare‑earth demand offers a more compelling case for a longer horizon if the firm can improve profitability and cash conversion.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • price perched at near‑support with bearish MACD divergence
  • decreasing volume amid extreme 30‑day volatility
  • negative operating and free cash flow limiting upside

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • robust revenue growth but persistently thin margins
  • valuation remains high relative to earnings and book value
  • moderate debt load but still reliant on future cash‑flow improvements

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • secular demand for rare‑earth materials in green energy and high‑tech sectors
  • potential for margin expansion as scale and product mix improve
  • low beta suggests a defensive profile over a multi‑year horizon

Key Metrics & Analysis

Financial Health

Revenue Growth52.60%
Profit Margin6.64%
P/E Ratio47.9
ROE7.60%
ROA3.29%
Debt/Equity36.64
P/B Ratio3.2
Op. Cash FlowCN¥-123407696
Free Cash FlowCN¥-1557971712

Technical Analysis

TrendBullish
RSI37.2
SupportCN¥23.93
ResistanceCN¥33.68
MA 20CN¥28.52
MA 50CN¥25.99
MA 200CN¥21.33
MACDBearish
VolumeDecreasing
Fear & Greed Index81.5

Valuation

GradeOvervalued
TypeBlend
Dividend Yield0.61%

Risk Assessment

Beta0.33
Volatility89.13%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.